Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

  • Martinolich J, Myneni AA, Boccardo J, Arbel E, Schwaitzberg S, Noyes E. (2024) Current Trends in Rectal Prolapse Repair Across New York State. American Society of Colon and Rectal Annual Scientific Meeting. Seattle, Washington (Feb)Poster
  • Brenner B, Xu F, Zhang Y, Kweon J, Fang R, Sheibani N, Zhang SX, Sun C, and Zhang, HF. (2024) Quantifying nanoscopic alterations associated with mitochondrial dysfunction using three-dimensional single-molecule localization microscopy. Biomed. Opt. Express (Feb), 15(3): 1571-1584. doi:10.1364/BOE.510351
  • Garvey C., Abi Fadel F., "Pulmonary Rehabilitation US Reimbursement Update: 2024". American Thoracic Society Pulmonary Rehabilitation Assembly Quarterly Bite. February 2024. https://www.thoracic.org/members/assemblies/assemblies/pr/quarterly-bite/pulmonary-rehabilitation-us-reimbursement-update-2024.php. (2024) (Feb)

Research Grants

  • Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.
  • NIH NCATS ASPIRE Design Award. Ram Samudrala (Principal Investigator). NIH. $100,000. 9/1/2019-1/1/2030.
  • NIH NCATS ASPIRE Reduction-to-Practice Award. Ram Samudrala (Co-Principal Investigator). NCATS. $1,220,000. 8/1/2021-1/1/2030.
  • Residency Training in Mental and Behavioral Health (PCTE-RTMB). Andrew Symons (Co-Principal Investigator). Health Resources and Services Administration. $2,500,000. 1/1/2023-12/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-9/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NIH National Eye Institute. 1/1/2018-9/1/2028.
  • Human miRNA Sequencing. Norma Nowak (Principal Investigator). VA. $183,213. 9/1/2023-9/1/2028.
  • Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers. Wilma Hofmann (Co-Investigator). NIH/NCI. 8/1/2023-7/1/2028.
  • Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers. Michael Buck (Co-Investigator). NCI. $3,823,553. 8/1/2023-7/1/2028.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2028.
  • Site Specific Drug Delivery with Light-responsive Conjugates for Photobiomodulation. Elizabeth Wohlfert (Co-Investigator). NIH. $2,011,250. 8/1/2023-6/1/2028.
  • Prognostic analysis and progression modeling of basal-like breast cancer using multiregion sequencing. Yijun Sun (Principal Investigator). NIH. $3,159,483. 6/1/2023-6/1/2028.
  • The Role of the Bed Nucleus of the Stria Terminalis-Norepinephrine System in Amphetamine-type Stimulant Use Disorders. Jinwoo Park (Principal Investigator). NIH/NIDA. $3,225,662. 9/1/2023-6/1/2028.
  • Genomic and functional investigations of the transcriptional regulatory network of tooth enamel development. Satrajit Sinha (Co-Investigator). NIH. $627,934. 7/1/2023-6/1/2028.
  • NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.